189 related articles for article (PubMed ID: 25218850)
1. Efficacy of the paramunity inducer PIND-ORF in the treatment of canine parvovirus infection.
Proksch AL; Unterer S; Truyen U; Hartmann K
Vet J; 2014 Nov; 202(2):340-7. PubMed ID: 25218850
[TBL] [Abstract][Full Text] [Related]
2. Influence of clinical and laboratory variables on faecal antigen ELISA results in dogs with canine parvovirus infection.
Proksch AL; Unterer S; Speck S; Truyen U; Hartmann K
Vet J; 2015 Jun; 204(3):304-8. PubMed ID: 25920770
[TBL] [Abstract][Full Text] [Related]
3. Faecal shedding of canine parvovirus after modified-live vaccination in healthy adult dogs.
Freisl M; Speck S; Truyen U; Reese S; Proksch AL; Hartmann K
Vet J; 2017 Jan; 219():15-21. PubMed ID: 28093104
[TBL] [Abstract][Full Text] [Related]
4. Vaccination with canine parvovirus type 2 (CPV-2) protects against challenge with virulent CPV-2b and CPV-2c.
Siedek EM; Schmidt H; Sture GH; Raue R
Berl Munch Tierarztl Wochenschr; 2011; 124(1-2):58-64. PubMed ID: 21306055
[TBL] [Abstract][Full Text] [Related]
5. Maternally-derived antibodies in pups and protection from canine parvovirus infection.
Decaro N; Campolo M; Desario C; Elia G; Martella V; Lorusso E; Buonavoglia C
Biologicals; 2005 Dec; 33(4):261-7. PubMed ID: 16168665
[TBL] [Abstract][Full Text] [Related]
6. Antibody levels and protection to canine parvovirus type 2.
Elia G; Cavalli A; Cirone F; Lorusso E; Camero M; Buonavoglia D; Tempesta M
J Vet Med B Infect Dis Vet Public Health; 2005; 52(7-8):320-2. PubMed ID: 16316392
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of feline anti-parvovirus antibodies in the treatment of canine parvovirus infection.
Gerlach M; Proksch AL; Unterer S; Speck S; Truyen U; Hartmann K
J Small Anim Pract; 2017 Jul; 58(7):408-415. PubMed ID: 28369886
[TBL] [Abstract][Full Text] [Related]
8. Passive protection of dogs against clinical disease due to Canine parvovirus-2 by specific antibody from chicken egg yolk.
Van Nguyen S; Umeda K; Yokoyama H; Tohya Y; Kodama Y
Can J Vet Res; 2006 Jan; 70(1):62-4. PubMed ID: 16548334
[TBL] [Abstract][Full Text] [Related]
9. [Application of paramunity inducers in small animal practice].
Proksch AL; Hartmann K
Tierarztl Prax Ausg K Kleintiere Heimtiere; 2016; 44(2):129-34. PubMed ID: 26998822
[TBL] [Abstract][Full Text] [Related]
10. Clinical evaluation of a single dose of immune plasma for treatment of canine parvovirus infection.
Bragg RF; Duffy AL; DeCecco FA; Chung DK; Green MT; Veir JK; Dow SW
J Am Vet Med Assoc; 2012 Mar; 240(6):700-4. PubMed ID: 22380808
[TBL] [Abstract][Full Text] [Related]
11. Simple tests for rapid detection of canine parvovirus antigen and canine parvovirus-specific antibodies.
Marulappa SY; Kapil S
Clin Vaccine Immunol; 2009 Jan; 16(1):127-31. PubMed ID: 18987166
[TBL] [Abstract][Full Text] [Related]
12. Assessment of serum antibody titers against canine distemper virus, canine adenovirus type II, and canine parvovirus in Alaskan sled dogs before and after a long-distance race.
Banse HE; McKenzie EC; Nelson S; Hinchcliff KW
J Am Vet Med Assoc; 2008 Jun; 232(11):1669-73. PubMed ID: 18518808
[TBL] [Abstract][Full Text] [Related]
13. Characterization of a canine parvovirus strain isolated from an adult dog.
Cavalli A; Bozzo G; Decaro N; Tinelli A; Aliberti A; Buonavoglia D
New Microbiol; 2001 Jul; 24(3):239-42. PubMed ID: 11497080
[TBL] [Abstract][Full Text] [Related]
14. Comparison of selected canine vaccines for their ability to induce protective immunity against canine parvovirus infection.
Larson LJ; Schultz RD
Am J Vet Res; 1997 Apr; 58(4):360-3. PubMed ID: 9099379
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the antigenic relationships among canine parvovirus type 2 variants.
Cavalli A; Martella V; Desario C; Camero M; Bellacicco AL; De Palo P; Decaro N; Elia G; Buonavoglia C
Clin Vaccine Immunol; 2008 Mar; 15(3):534-9. PubMed ID: 18160619
[TBL] [Abstract][Full Text] [Related]
16. Canine parvovirus type 2 (CPV-2) serological and molecular patterns in dogs with viral gastroenteritis from southern Brazil.
Truyen LH; Flores RS; de Oliveira Santana W; Abreu MB; Brambatti G; Lunge VR; Streck AF
Braz J Microbiol; 2024 Jun; 55(2):1979-1986. PubMed ID: 38407780
[TBL] [Abstract][Full Text] [Related]
17. Do two current canine parvovirus type 2 and 2b vaccines provide protection against the new type 2c variant?
Larson LJ; Schultz RD
Vet Ther; 2008; 9(2):94-101. PubMed ID: 18597247
[TBL] [Abstract][Full Text] [Related]
18. Evidence for immunisation failure in vaccinated adult dogs infected with canine parvovirus type 2c.
Decaro N; Desario C; Elia G; Martella V; Mari V; Lavazza A; Nardi M; Buonavoglia C
New Microbiol; 2008 Jan; 31(1):125-30. PubMed ID: 18437851
[TBL] [Abstract][Full Text] [Related]
19. Self-assembly of virus-like particles of canine parvovirus capsid protein expressed from Escherichia coli and application as virus-like particle vaccine.
Xu J; Guo HC; Wei YQ; Dong H; Han SC; Ao D; Sun DH; Wang HM; Cao SZ; Sun SQ
Appl Microbiol Biotechnol; 2014 Apr; 98(8):3529-38. PubMed ID: 24413974
[TBL] [Abstract][Full Text] [Related]
20. Serum distemper virus and parvovirus antibody titers among dogs brought to a veterinary hospital for revaccination.
McCaw DL; Thompson M; Tate D; Bonderer A; Chen YJ
J Am Vet Med Assoc; 1998 Jul; 213(1):72-5. PubMed ID: 9656027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
